Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.

Slides:



Advertisements
Similar presentations
Colon Cancer The life time risk of developing Colon Cancer in the United States in one in sixteen. This means 144,000 new cases a year accounting for.
Advertisements

Familial adenomatous polyposis
Pathophysiology Colon CA. Most colorectal cancers, regardless of etiology, arise from adenomatous polyps. Polyp - a grossly visible protrusion from the.
Hereditary GI Cancer Syndromes: Keys to identify high risk patients
Mismatch Repair Deficiency Testing Kenneth J. Bloom, MD, FCAP Chief Medical Officer, Clarient, a GE Healthcare Company.
Colorectal Adenomas Santhat Nivatvongs MD Mayo Clinic Rochester Minnesota U. S.A.
The Adenoma/Carcinoma Sequence in the Colon
Gene 210 Cancer Genomics April 29, Key events in investigating the cancer genome M R Stratton Science 2011;331:
Surveillance colonoscopy after polypectomy – how frequent? Dr Chu Ming Leong Tuen Mun Hospital 1.
Screening for Colorectal Cancer Cancer Symposium: Measuring the Benefits of Screening and Treatment October 2007.
A few thoughts on cancer and cancer family syndromes Pamela McGrann, MD. Department of Medical Genetics.
COLORECTAL BLEEDING: a multidisciplinary approach Torino, 31 marzo-1 aprile 2006 GENETIC EVALUATION Schena M, Angelini F, Bertetto O. Department of Medical.
Colorectal Cancer Ramon Garza III, M.D.. Colorectal CA DNA Sequencing Mismatch Repair Genes Genomics Role of PCR and FISH in Colon CA.
Hereditary Colon Cancer ACP, October 2013 Steve Lanspa MD, FACP.
Lecture 22 Cancer Genetics II: Inherited Susceptibility to Cancer Stephen B. Gruber, MD, PhD November 19, 2002.
Mechanisms and Epidemiology of Colon Cancer
Hereditary Colorectal Cancer: An Overview Felice Schnoll-Sussman,MD Jay Monahan Center for Gastrointestinal Health New York Hospital/ Weill Cornell Medical.
Familial Colorectal Cancers Francis M. Giardiello, M.D. The Johns Hopkins University.
Morning Report May 20, 2009 Bridger Clarke  Born in Lawrence, Massachusetts, on 4 January  Dropped out of high school at the age of fourteen.
Gene 210 Cancer Genomics May 5, Key events in investigating the cancer genome M R Stratton Science 2011;331:
DR Jameel Tariq Miro.  Lifetime incidence 5%  90% of cases occur after age 50  One-third of patients with colorectal cancer die from the disease 
MSH2 and Human Nonpolyposis Colon Cancer Yael Aschner.
Issues in Genetic Testing: Real versus Not-so-Real Roberta A Pagon, MD Principal Investigator, GeneTests Professor, Pediatrics University of Washington.
Colorectal cancer in Norway Maria Mai Ingvild Hvalby.
Joint Hospital Surgical Grand Round 19 June 2004.
Update on Colon Cancer Screening and Prevention
Update on Colorectal Cancer Screening Tests Source: Levin Bernard et al. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous.
West Midlands Regional Genetics Laboratory
1 The Chemoprevention of Sporadic Colorectal Cancer Issues Surrounding a Benefit/Risk Analysis in Clinical Trials Mark Avigan MD CM Medical Officer Division.
Building a Model of Tumorigenesis: A small group activity for a Cancer Biology/Cell Biology course L. K. Wright Supplemental File : Multistep Tumorigenesis.
Lifestyle and prevention of colon cancer Clara Natoli, Chieti.
Benchmarking For Colonoscopy
High risk population in GI field how we can find them? Ahmad Shavakhi MD Associate professor of gastroenterology.
Colorectal carcinoma Dr.Mohammadzadeh.
CONFIDENTIAL PillCam ™ COLON PillCam™ COLON has received a CE Mark, but is not cleared for marketing or available for commercial distribution in the USA.
Slides last updated: June 2015 CRC: CLINICAL FEATURES.
New Era of Genetic Testing in Colon Cancer
Familial Cancer. General Principles Mutations inherited through germ cells contribute to a minority of tumours Two hits usually needed germline/somatic.
Management of Serrated Polyps of Colorectum Eric YF Cheung Department of Surgery, NDH.
Epidemiology of Colorectal Cancer Edward Giovannucci, M.D., Sc.D. Harvard School of Public Health Brigham and Women’s Hospital and Harvard Medical School.
Familial Risk and Surveillance of Colon and Rectum Malcolm Dunlop Academic Coloproctology & Colon Cancer Genetics Group University of Edinburgh & Western.
Colorectal cancer (CRC) Professor Yaron Niv Rabin Medical Center Tel Aviv University.
What are Microsatellites? D2S123 TAGGCCACACACACACACACA Unique Primer Mono, di, tri, tetra nucleotide repeats HNPCC - Expansion/contraction of nl repeats.
Colon polyps Peter Stanich, MD
Evaluation Of Colonic Polyps Kathia E. Rosado Orozco MD GI and Liver Pathologist Hato Rey Pathology Associates.
Screening for Colorectal Cancer (CRC) Nov, 2007 A Aljebreen, FRCPC Division of Gastroenterology KKUH, Riyadh.
Serrated Polyps of the Colon Aaron Sinclair, MD University of Kansas School of Medicine – Wichita Department of Family and Community Medicine Wesley Family.
CT Colonography vs Colonoscopy for the Detection of Advanced Neoplasia David H. Kim, M.D., Perry J. Pickhardt, M.D., Andrew J. Taylor, M.D., Winifred K.
Types of Genes Associated with Cancer
Chapter 11 Cancer Genetics. Cell responses to environmental signals.
The Malignant Polyp Handout Version Hans Elzinga, MD Program Director- Advanced Procedures in Family Medicine Fellowship Salud Family Health Center-Longmont,
Gastroenterological Society of Queensland Young Investigator Awards The Traditional Serrated Adenoma A Clinicopathological and Molecular Analysis Presented.
Am J Gastroenterol 2012; 107:1213– June 2012 R3. 김동희 /prof. 이창균.
Do we need colonoscopy in patients with gastric adenoma? The risk of colorectal adenoma in patients with gastric adenomas R3 Kim Jungwook Moon Hee Yang,
MLH1 and HNPCC March 29, 2005 Tammy Jernigan
West Midlands Regional Genetics Laboratory
27th Annual Winter CME Conference
Colorectal Cancer (CRC)
Irritable Bowel Syndrome
A Visual Tour of Effective Colonoscopy
MLH1 Mutations and the Formation of Hereditary Non-Polyposis Colon Cancer(Lynch Syndrome) Kevin Harris Hereditary Non-polyposis Colorectal Cancer (HNPCC)
Colorectal cancer : Three pathways
A Visual Tour of Effective Colonoscopy
Genomic and Epigenetic Instability in Colorectal Cancer Pathogenesis
Erratum Gastrointestinal Endoscopy
Colonic polyps and tumors
Risks of interval colorectal cancer in a FIT-based screening program
Evaluation of Markers for CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer by a Large Population-Based Sample  Shuji Ogino, Takako Kawasaki,
Presentation transcript:

Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013

Polyp-Cancer sequency ?

Morphology, Anatomic Distribution and Cancer Potential of Colonic Polyps. Annals Surgery 1979;190:

Familiar adenomatous polyposis (FAP) APC mutations (Adenomatous polyposis coli) An inherited cancer-predisposition syndrome more than 100 adenomatous polyps in carriers of the mutant gene, the risk of colorectal cancer by the age of 40 years is almost 100% Kathleen H. Biology Of The APC Tumor Suppressor. J Clin Oncol 2000;18:

Animal model: The Apc min mouse – chemical mutagenesis that introduced a chain- terminating mutation at nucleotide 2549 in mApc – develop numerous intestinal adenomas in which the remaining wild-type allele is somatically inactivated during adenoma development Kathleen H. Biology Of The APC Tumor Suppressor. J Clin Oncol 2000;18:

Sporadic colorectal adenoma and cancers APC – Somatic mutations and deletions that inactivate both copies of APC are present in most patients Wild-type APC – Mutations of β-catenin  resistent to the β- catenin degradation complex Kathleen H. Biology Of The APC Tumor Suppressor. J Clin Oncol 2000;18:

Sanford D. Moleucular Basis of Colorectal Cancer. N Engl J Med 2009;361:

Methods Study population – Prospective cohort study The Nurses’ Health Study: 121,700 U.S. female nurses (30~55 y/o), since 1976 The Health Professionals Follow-up Study: 51,529 U.S. male health professionals (40~75 y/o), sinc 1986 Exclusion criteria – History of cancer – Ulcerative colitis – Colorectal polyps – Familiar polyposis syndromes – Previous lower endoscopy

Observational studies – Enrolled: n=88,902 (31,736 men, 57,166 women) – 1998~2008 – Questionnaire and collect information every 2 year (Low GI endoscopy: sigmoidscopy or colonoscopy) – Incidence analysis in 2010, mortality analysis in 2012

Polyps – Adenomatous polyps – Advanced adenoma (≥10 mm, tubulovillus or villous, or high-grade dysplasia) – High-risk adenoma ( numbers ≥ 3) – Colonoscopic polypectomy: excision of comfirmed adenomatous polyps (excluding hyperplastic polyps) – Negative endoscopy: no adenomas or CRCs

Molecular analysis – Microsatellite instability status – BRAF (codon 600) – KRAS (codon 12 and 13) – PIK3CA (exons 9 and 20) – DNA methylation (8 CpG island methylator phenotype, CIMP) Specific promotors: MLH1, CACNA1G, CDKN2A, CRABP1, IGF2, NEUROG1, RUNX3, and SOCS1) Long interspersed nucleotide element 1 (LINE-1)

Results 88,902 participants, follow-up for 22 years – Received endoscopy vs. without endoscopy – Colorectal cancer: 1815 incident cases (2%)

Screen colonscopy interval

Surveillance colonoscopy interval after removal of adenomatous polyps

Summary Low gastrointestinal endoscopy is associated with a low incidence and low mortality of colorectal cancer Tumor molecular features of the serrated pathway might be involved in the development of cancer within 5 years after colonoscopy